CMA Decline Drives Age-Related Muscle Myopathy

Skeletal muscle must continuously remove damaged or surplus proteins while preserving contractile structures and organelles. The reference study, Age-related decline of chaperone-mediated autophagy in skeletal muscle leads to progressive myopathy, examines a selective lysosomal pathway that has received less attention in muscle biology than macroautophagy and the ubiquitin–proteasome system. Its central conclusion is that chaperone-mediated autophagy (CMA) is required for muscle integrity and that its decline with ageing contributes directly to functional deterioration.

Study Background and Research Question

Macroautophagy removes cytoplasmic material through autophagosome formation, whereas CMA transfers individual substrate proteins directly across the lysosomal membrane. In CMA, proteins containing KFERQ-like motifs are recognized by HSC70 and delivered to lysosomes through lysosome-associated membrane protein 2A (LAMP2A). Because LAMP2A is the rate-limiting component of the pathway, changes in its abundance and lysosomal stability can substantially alter CMA capacity.

Earlier work had established that CMA activity decreases in several ageing-associated diseases and in skeletal muscle from old animals, but the physiological consequences of this decline were unclear. The study therefore addressed three related questions: how muscle CMA responds to stressors such as starvation, exercise, repair, and obesity; whether loss of CMA is sufficient to cause muscle pathology; and which protein substrates and organelle systems explain the resulting phenotype. The authors also asked whether increasing CMA activity in old muscle could improve age-associated defects.

Key Innovation from the Reference Study

The major innovation is the integration of pathway monitoring, tissue-specific genetics, quantitative proteomics, calcium physiology, and translational human-muscle analysis. Rather than inferring CMA function from LAMP2A expression alone, the authors used a KFERQ-Dendra2 reporter to measure delivery of CMA-targeted cargo to lysosomes in vivo. This distinction is important because a change in LAMP2A abundance does not necessarily indicate how many lysosomes are functionally competent for CMA.

The muscle-specific Lamp2a knockout model provides a stronger test of causality. It allows the consequences of CMA loss to be separated from systemic effects that can accompany ageing, fasting, obesity, or illness. Comparative proteomics then connects the pathway defect to specific changes in the mitochondrial proteome and identifies the sarcoplasmic–endoplasmic reticulum Ca²⁺-ATPase, SERCA, as a CMA substrate. This places selective lysosomal proteolysis upstream of calcium storage and excitation–contraction regulation, extending the significance of CMA beyond general protein quality control.

Methods and Experimental Design Insights

The experimental design uses complementary readouts rather than a single marker. KFERQ-Dendra2 fluorescence reports CMA cargo delivery, while LAMP1 staining provides context about the endolysosomal compartment. Quantifying puncta per myofibre area helps account for differences in fibre size and cellular composition. The study also evaluates transcriptional responses through expression analysis of CMA-related genes and a composite CMA score, allowing pathway activity to be considered at both functional and regulatory levels.

For causal analysis, the authors generated muscle-specific Lamp2a-deficient mice using the HSA-Cre:L2A^fl/fl strategy, referred to as HSAL2A^−/−. Muscle force measurements and histological assessment were paired with proteomic comparisons between deficient and control muscle. This combination is valuable because a molecular change becomes biologically meaningful only when it corresponds to impaired force production, fibre degeneration, or other structural abnormalities.

The study further compares physiological induction of CMA with pathological suppression. Starvation experiments test a known CMA stimulus, while exercise and tissue-repair settings address whether the pathway is recruited during increased metabolic demand or regeneration. Obesity and ageing provide disease-relevant contexts. Finally, human skeletal-muscle samples are used to determine whether the age-associated direction of change observed in mice is also present in people.

Protocol Parameters

• CMA reporter: Use KFERQ-Dendra2-expressing mice and quantify Dendra2-positive puncta in muscle fibres as an in vivo measure of CMA cargo delivery, as performed in the reference study.
• Lysosomal context: Co-stain for LAMP1 so that changes in CMA-competent lysosomes can be distinguished from changes in the total endolysosomal compartment.
• Starvation comparison: The study examined 24-hour and 48-hour starvation in 6-month-old mice and analysed gastrocnemius muscle; these values are literature-backed parameters rather than universal protocol requirements.
• Genetic causality: Compare muscle-specific Lamp2a-deficient animals with appropriate controls using force testing, fibre morphology, and proteomic analysis rather than relying on reporter intensity alone.
• Translational validation: Assess LAMP2A or CMA-related activity in human skeletal muscle when possible, while interpreting cross-sectional human data as evidence of association rather than proof of causality.

One practical design lesson is the need to separate the number of lysosomes from their functional state. In the starvation experiments, the increase in reporter puncta reflected a greater proportion of lysosomes becoming CMA competent, while total endolysosome abundance did not change in the same way across sexes. The authors also observed a stronger starvation-associated CMA response in females, underscoring the value of sex-balanced analysis in muscle-proteostasis studies.

Core Findings and Why They Matter

CMA was induced in skeletal muscle by starvation, exercise, and tissue repair, indicating that the pathway responds to both nutrient stress and increased tissue demand. In contrast, CMA declined with ageing and obesity. In skeletal muscle, starvation was associated with transcriptional upregulation of the CMA network, including Lamp2a, whereas starvation-induced CMA in liver is more strongly associated with post-transcriptional regulation. This tissue-specific distinction suggests that muscle adapts its proteostasis machinery differently from other organs.

Loss of CMA in muscle caused a progressive myopathy characterized by reduced muscle force and degenerative myofibre features. The phenotype supports a direct role for CMA in maintaining muscle structure rather than merely reflecting secondary damage caused by systemic ageing. Proteomic analysis revealed changes in mitochondrial proteins, consistent with impaired organelle quality control and altered energy-handling capacity.

SERCA emerged as a particularly important mechanistic link. When CMA is impaired, defective SERCA turnover is associated with abnormal calcium storage and dysregulated calcium dynamics. Because calcium handling controls contraction, relaxation, and multiple signalling pathways, this result offers a plausible explanation for how a lysosomal degradation defect can produce a measurable decline in muscle performance. It also broadens the interpretation of muscle atrophy biology: impaired proteostasis may alter function before or alongside major loss of muscle mass.

The human-muscle analysis confirmed that CMA is downregulated with age, strengthening the relevance of the mouse findings. Conversely, genetically increasing CMA activity in old mice partially improved skeletal-muscle ageing phenotypes. The rescue was incomplete, so the data do not imply that CMA restoration alone reverses biological ageing. They do, however, identify CMA capacity as a modifiable component of muscle maintenance and a potential target for mechanistic studies of sarcopenia and age-related weakness.

Comparison with Existing Internal Articles

The internal resource MG-262 precision proteasome inhibition in cell models focuses on experimental workflows for perturbing the ubiquitin–proteasome system, including protein accumulation, apoptosis, and cell-cycle responses. Its relationship to the reference study is complementary rather than interchangeable. The Nature Metabolism paper investigates selective lysosomal degradation through CMA and establishes a muscle-specific Lamp2a-dependent mechanism; a proteasome workflow can help test how UPS activity changes alongside CMA loss, but it cannot serve as a direct readout of LAMP2A-mediated lysosomal import.

This distinction matters when interpreting proteostasis experiments. Broad accumulation of ubiquitinated proteins, altered viability, or cell-cycle effects should not automatically be attributed to defective CMA. Researchers should pair pathway-specific genetic or reporter measurements with orthogonal functional assays, particularly when comparing lysosomal degradation with proteasome-dependent turnover.

Limitations and Transferability

The reporter provides a useful in vivo estimate of CMA cargo delivery, but fluorescence puncta remain an indirect measure of flux and depend on reporter expression, lysosomal accessibility, imaging quality, and quantitative normalization. LAMP1 co-staining improves interpretation but does not by itself establish substrate degradation. Likewise, proteomic enrichment and the observed consequences of Lamp2a loss support SERCA as a CMA substrate, yet substrate handling may vary with fibre type, disease state, and cellular stress.

The muscle-specific knockout model establishes causality in mice but does not reproduce the full complexity of human ageing, including multimorbidity, physical activity, nutrition, endocrine changes, and medication exposure. The human analysis supports age-associated CMA downregulation but is not equivalent to a longitudinal intervention study. Sex-dependent responses in the starvation experiments also caution against assuming that a single CMA response applies uniformly across biological backgrounds.

Finally, partial improvement after genetic CMA upregulation indicates that muscle ageing involves multiple interacting defects. Mitochondrial changes, calcium dysregulation, macroautophagy, and proteasome-mediated degradation may influence one another. Future work should therefore distinguish whether restoring CMA corrects primary defects in substrate turnover, improves calcium handling secondarily, or changes broader proteostasis network coordination. These limitations define the study's transferability without weakening its central conclusion that CMA is an essential component of skeletal-muscle homeostasis.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

CMA and the ubiquitin–proteasome system remove different but overlapping classes of cellular proteins. A proteasome perturbation can therefore be useful as a parallel condition when investigating whether CMA-deficient muscle or cultured cells compensate through another degradation route. This is a mechanistically informed extension of the reference findings, not a direct replication of the reported CMA experiments. The evidence for CMA-dependent SERCA turnover and age-related muscle dysfunction is established by the cited study; any conclusion about compensation by proteasome activity requires separate controls and pathway-specific assays.

For complementary ubiquitin–proteasome workflows, researchers can use MG-262 (Z-Leu-Leu-Leu-B(OH)2) (SKU A8179). The product information describes this boronic peptide acid as a potent, reversible, cell-permeable inhibitor of proteasome chymotryptic activity. It may support a proteasome inhibition assay and related apoptosis research or cell cycle arrest studies; reported osteoclast differentiation inhibition is a separate application and should not be inferred from the CMA findings. Because it targets the proteasome rather than LAMP2A-dependent lysosomal import, use it as a complementary perturbation with vehicle controls, pathway-specific CMA measurements, and freshly prepared solutions according to the product information.